Skip to content
Open access

CD200R1 Marks a Branch Point During Human Natural Killer Cell Development in Tonsils

Nov 2026 · bioRxiv · 0 citations · 107 references
Biology

TL;DR

Ex vivo single-cell transcriptomic, DNA methylation, phenotypic, and functional analyses demonstrate that CD200R1⁺ stage 4A cells represent an immature, oligopotent precursor population enriched for tissue-resident and cytokine-responsive programs.

Abstract

Human natural killer (NK) cells arise from common innate lymphoid cell progenitor and precursor populations that are selectively enriched within secondary lymphoid tissues and that complete their terminal differentiation through stages of progressively lineage-restricted downstream developmental intermediates. We identify two subsets of tonsil CD94/NKG2A+NKp80⁻ “stage 4A” NK cell development intermediates that show differential expression of the inhibitory receptor, CD200R1. Ex vivo single-cell transcriptomic, DNA methylation, phenotypic, and functional analyses demonstrate that CD200R1⁺ stage 4A cells represent an immature, oligopotent precursor population enriched for tissue-resident and cytokine-responsive programs. In contrast, CD200R1⁻ stage 4A cells show more restricted NK cell developmental potential concomitant with features of mature NK cells. These findings help to refine the human NK cell developmental pathway in tonsils and highlight CD200R1 as a useful marker delineating an uncommitted developmental state linking microenvironmental cues to NK cell maturation and plasticity.

Read PDF

Similar papers

Open access Oct 2026

T-BET promotes inflammatory specialization without driving terminal maturation of iPSC-derived NK cells

Induced pluripotent stem cells (iPSCs) provide a scalable platform for off-the-shelf immune cell therapies; however, the mechanisms controlling maturation and functional specialization of iPSC-derived natural killer (iNK) cells are not fully understood. In this study, we combined single-cell transcriptomics, phenotypic...

C. Marsal, Muhammad Kashif, Sophia Borate et al. · 0 citations
Open access Sep 2026

CD98hc marks a precursor of human stem cell-derived alpha cells primed for functional maturation

Introduction Pluripotent stem cell-derived alpha cells (SC-α cells) represent a promising component of next-generation cell therapies designed to more fully recapitulate human islet function; however, heterogeneity and the presence of undesired side populations limit their functional maturity and therapeutic potential....

Sean Lewis-Brinkman, Tiana Salomon, Kyle R. Knofczynski et al. · 0 citations
Open access Oct 2026

Early-life human lymphopoiesis generates a distinct B-cell lineage

We characterize the first wave of human B-lymphopoiesis across gestation (n=42 donors) and identify a developmentally and functionally distinct B-cell lineage that shapes antibody specificity before birth. The earliest lymphoid progenitors engage an evolutionarily conserved genetic program enriched for imprinted genes...

Alexandra F. Nazzari, Krishna Kothari, Jun-Kai Yang et al. · 0 citations
Open access Sep 2026

Upregulation of CD90 correlates with T lineage commitment at the DN2a stage of T cell development

Early thymic progenitors (ETPs) retain the potential for alternative fates but commit to the T-cell lineage as they progress through the CD4−CD8− double-negative (DN) thymocyte stages early in T-cell development. Current evidence suggests that T-lineage commitment occurs during the transition from the DN2a to DN2b stag...

Dhruti Parikh, Karen Gu, Sara Tomei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.